0001127602-20-013125.txt : 20200403 0001127602-20-013125.hdr.sgml : 20200403 20200403162222 ACCESSION NUMBER: 0001127602-20-013125 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200402 FILED AS OF DATE: 20200403 DATE AS OF CHANGE: 20200403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POPS RICHARD F CENTRAL INDEX KEY: 0001126490 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 20773654 MAIL ADDRESS: STREET 1: 10555 SCIENCE CENTER DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-04-02 0001520262 Alkermes plc. ALKS 0001126490 POPS RICHARD F CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 1 Director and CEO, Alkermes plc Ordinary Shares 2020-04-02 4 M 0 50000 11.74 A 809094 D Ordinary Shares 2020-04-02 4 S 0 50000 13.79 D 759094 D Employee Stock Option (Right to Buy) 11.74 2020-04-02 4 M 0 50000 0 D 2020-05-17 Ordinary Shares 50000 125000 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.37 to $14.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Shantale Greenson, attorney-in-fact for Richard F. Pops 2020-04-03